US wrap: Accelerated growth still popular with cautious investors

emerging market
US investors given access to developed and emerging markets

The latest offering consists of two accelerated growth products, a structure which is gaining popularity in the US as investors look for yield and protection barriers. However, bankers say that investors are still very cautious and appetite is mainly for principal-protected products, though all issuance is slowing down if recent volumes are anything to go by.

Exposure to the MSCI Emerging Markets index is offered through both products, although the UBS product accesses it via the fund tracking

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here